Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
07/2009
07/02/2009US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
07/02/2009CA2709635A1 Polypeptide-nucleic acid conjugates and uses thereof
07/02/2009CA2708626A1 Recovery of hydrophobic peptides from oils
07/01/2009EP2074142A1 Compounds for stimulating p-glycoprotein function and uses thereof
07/01/2009EP2074138A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor
07/01/2009EP2074137A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy
07/01/2009EP2074134A1 Method for peptide synthesis
07/01/2009EP2073829A2 Stabilized therapeutic small helical antiviral peptides
07/01/2009EP1951747B1 Process and intermediates for the synthesis of caspofungin
07/01/2009EP1713439B1 Pharmaceutical preparation for the oral cavity
07/01/2009EP1673633B1 Method for detecting feline immunodeficiency virus
07/01/2009EP1583564B1 Improved linkers for radiopharmaceutical compounds
07/01/2009EP1301486B1 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
07/01/2009EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon
07/01/2009CN101469016A Trichosanthin protein derived peptide and use thereof
07/01/2009CN100507563C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination
07/01/2009CN100506981C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/2009
06/30/2009US7553962 Cross-linked glycopeptide-cephalosporin antibiotics
06/30/2009US7553929 Administering nuclear factor kappa beta (nf-kb)peptide nuclear localization sequence to inhibit import of stress-responsive transcription factor; septic shock, skin disorders, autoimmune diseases
06/30/2009CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
06/30/2009CA2108119C Glial mitogenic factors, their preparation and use
06/25/2009WO2009079053A2 High affinity metal-oxide binding peptides with reversible binding
06/25/2009WO2009078977A2 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins
06/25/2009WO2009078820A1 Cationic core-shell peptide nanoparticles
06/25/2009WO2009077401A1 Antitumoral compounds
06/25/2009WO2009076966A2 Rhoc-based immunotherapy
06/25/2009WO2009010733A3 Peptide gap junction modulators
06/25/2009US20090163844 Methods for the treatment or prevention of scars and/or keloids
06/25/2009US20090163695 Process for the preparation of bicyclic peptide compounds
06/25/2009US20090163426 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs
06/25/2009US20090163425 Peptide Inhibiting Angiotensin Converting Enzyme
06/25/2009US20090163423 Exendins and Exendin Agonist Analogs to Regulate Gastrointestinal Motility
06/25/2009US20090163413 Dental products comprising bone growth enhancing peptide
06/25/2009US20090163410 Novel Peptides and the Biological Use Thereof
06/25/2009US20090163405 Angiogenic peptides and uses thereof
06/25/2009US20090162875 Peptide diagnostic agent for lyme disease
06/25/2009US20090162845 Affinity tag nucleic acid and protein compositions, and processes for using same
06/25/2009US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
06/25/2009US20090162437 Modified self-assembling peptides
06/25/2009US20090162375 Resistin antagonists and their use
06/25/2009US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease
06/25/2009US20090162332 Methods and compositions for treating brain diseases
06/25/2009US20090162296 Approach to treat intraocular hypertension
06/25/2009CA2710061A1 Rhoc-based immunotherapy
06/25/2009CA2708080A1 Antitumoral compounds
06/24/2009EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
06/24/2009EP1513869B1 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids
06/24/2009CN101466729A Lysobactin amides
06/24/2009CN100503634C T4 synthetic product and application thereof
06/23/2009US7550560 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving
06/23/2009US7550558 Antimicrobial peptides and methods for identifying and using such peptides
06/23/2009US7550430 Bactericides; immobilized
06/23/2009US7550428 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water
06/23/2009US7550425 Diuretic peptide conjugates
06/23/2009CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
06/18/2009WO2009076672A1 Advantageous salts of mu-opiate receptor peptides
06/18/2009WO2009074628A1 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis
06/18/2009WO2009074569A1 Targeting and therapeutic compounds with a polyproline-comprising spacer and gas-filled microvesicles comprising said compounds
06/18/2009WO2004039962A3 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
06/18/2009WO2003089458A3 Conjugates of membrane translocating agents and pharmaceutically active agents
06/18/2009US20090156785 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease
06/18/2009US20090156508 Synthetic peptide amides and dimeric forms thereof
06/18/2009US20090156505 Self-assembly and mineralization of peptide-amphiphile nanofibers
06/18/2009US20090156499 Antimicrobial Peptides and Methods of Identifying the Same
06/18/2009US20090156490 Peptides for diagnostic and therapeutic methods for celiac sprue
06/18/2009US20090156472 Cyclic Depsipeptides
06/18/2009US20090155843 Tnf antagonists
06/18/2009US20090155335 Non-leaching non-fouling antimicrobial coatings
06/18/2009US20090155310 Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
06/18/2009US20090155306 Pamps, pathogen associated molecular patterns
06/18/2009US20090155304 Modified Cyanovirin-N Polypeptide
06/18/2009US20090151600 Adhesive protein extracted from Mytilus galloprovincialis, Mytilus galloprovincialis foot protein-5; can be used as medical adhesives as they are non-toxic to the human body and do not impose immunogenicity; water-resistant bioadhesives
06/18/2009CA2707733A1 Advantageous salts of mu-opiate receptor peptides
06/17/2009EP2071335A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis
06/17/2009EP2070944A1 Specific binding agents of human angiopoietin-2
06/17/2009EP2069388A2 Peptides derived from the c2 domain of epsilon pkc, and use thereof
06/17/2009EP2069308A2 Azonafide derived tumor and cancer targeting compounds
06/17/2009EP1896386A4 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
06/17/2009EP1790654B1 Peptide capable of binding to insulin-binding protein and adsorbent
06/17/2009EP1780215B1 Crohn's disease antibody epitope peptide and reagent for testing crohn's disease
06/17/2009EP1735345B1 Processes for preparing eptifibatide and pertinent intermediate compounds
06/17/2009EP1527341B1 Interfacial biomaterials
06/17/2009EP1140131B1 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases
06/17/2009CN101456902A Microorganism metabolites feed supplement cyclic decapeptide and application
06/17/2009CN101456901A 12 peptide ZA for inhibiting hepatitis c virus to infect human cell and preparation method and application
06/17/2009CN101456900A 12 peptide ZB for inhibiting hepatitis c virus to infect human cell and preparation method and application
06/17/2009CN101456899A 12 peptide ZD for inhibiting hepatitis c virus to infect human cell and preparation method and application
06/17/2009CN100500692C Novel LHRH antagonists, preparation method and pharmaceutical use thereof
06/17/2009CN100500209C CLK-peptide and SLK-peptide
06/16/2009US7547759 Stimulating cytotoxic T-lymphocytes
06/16/2009US7547677 Peptide or fusion protein containing peptide binds to gut of sap-sucking insects, e.g., aphids; when bound, peptide inhibits binding of targeted virus to insect gut; when peptide is expressed in fluids of transgenic plants, is taken up by insect with sap, binds to gut receptors, inhibits transmission
06/16/2009US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide
06/16/2009CA2192786C Cyclopeptolide inhibitors of adhesion molecules
06/11/2009WO2009073168A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
06/11/2009WO2009072610A1 Cancer vaccine composition
06/11/2009WO2009072609A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof
06/11/2009WO2009072608A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof
06/11/2009WO2009072555A1 Cancer vaccine
06/11/2009WO2009071486A1 Human cd154-binding synthetic peptide and uses thereof
06/11/2009WO2009071276A2 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides